SAN DIEGO, CA, Resolute Science, preclinical-stage biotechnology company, received funding from NuFund.
NuFund, a leading venture group, is thrilled to announce its investment in Resolute Science, Inc., a preclinical-stage biotechnology company developing a novel class of pan-cancer therapeutics for the treatment of aggressive and hard-to-treat solid tumors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
